Welcome to our dedicated page for Forian news (Ticker: FORA), a resource for investors and traders seeking the latest updates and insights on Forian stock.
Forian Inc. reports developments tied to its data science-driven information and analytics business for life science, healthcare and financial services customers. Its updates center on proprietary data management capabilities, large-scale healthcare data assets, and analytics products used to measure operational, clinical and financial performance across life sciences, payer and provider markets.
Recurring news themes include quarterly financial results, data-platform investment, customer and marketplace access, and product activity around information assets such as Chartis and the Chronos data lake. Forian's completed acquisition of Kyber Data Science added machine learning-enabled healthcare analytics for financial services customers, while partnerships such as Databricks Marketplace distribution expand access to its healthcare information products.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Forian Inc. (Nasdaq: FORA) reported a 37% year-over-year revenue growth in Q4 2022, totaling $7.9 million, with healthcare information revenue increasing 64%. The company reduced its net loss to $3.6 million or $0.11 per share, down from $8.0 million in Q4 2021. For the full year, total revenue reached $28.0 million, a 66% increase from 2021. Forian divested BioTrack for $30 million in February 2023, enhancing its balance sheet. The company expects 25% to 37% revenue growth in healthcare information in 2023, aiming for positive adjusted EBITDA in the second half of the year.
Forian Inc. (Nasdaq: FORA) announced it will release its fourth quarter and full year 2022 financial results on March 27, 2023, after market close. A conference call and webcast will follow at 4:30 p.m. (ET) the same day. Investors can register for the call and access the webcast live on the company’s website. Forian provides data science-driven information and analytics solutions to healthcare and life sciences sectors, focusing on optimizing operational and financial performance for its clients. Forward-looking statements highlight potential risks and uncertainties that may affect future performance, suggesting caution in reliance on these projections.